For patients seeking prostate cancer treatment with the absolute minimum risk of long-term side effects like urinary incontinence and erectile dysfunction, active surveillance or advanced focal therapies (such as focal laser ablation, targeted high-intensity focused ultrasound, or focal cryotherapy) are widely considered optimal choices. By treating only the discrete tumor lesion rather than ablating or removing the entire prostate gland, these localized interventions preserve surrounding neurovascular bundles and urinary structures, resulting in drastically lower rates of permanent functional complications while maintaining robust cancer control.